메뉴 건너뛰기




Volumn 146, Issue 2, 2010, Pages 212-218

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer

Author keywords

Breast cancer; Doxorubicin; Localized chemotherapy; Polymeric drug carrier

Indexed keywords

BIOPOLYMERS; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DIAGNOSIS; HISTOLOGY; MAMMALS; TARGETED DRUG DELIVERY; TISSUE; TOXICITY;

EID: 77955413486     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.04.006     Document Type: Article
Times cited : (157)

References (33)
  • 1
    • 33847096349 scopus 로고    scopus 로고
    • Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management
    • Takemura G., Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 2007, 49(5):330-352.
    • (2007) Prog. Cardiovasc. Dis. , vol.49 , Issue.5 , pp. 330-352
    • Takemura, G.1    Fujiwara, H.2
  • 5
    • 85081448520 scopus 로고    scopus 로고
    • National Cancer Institute: Breast cancer PDQ treatment,<> Access date 10/29/2009.
    • National Cancer Institute: Breast cancer PDQ treatment, 2007, <> Access date 10/29/2009. http://www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional.
    • (2007)
  • 8
    • 0024351669 scopus 로고
    • Turnover and metabolism of hyaluronan
    • discussion 53-49, 281-285
    • Fraser J.R., Laurent T.C. Turnover and metabolism of hyaluronan. Ciba Found. Symp. 1989, 143:41-53. discussion 53-49, 281-285.
    • (1989) Ciba Found. Symp. , vol.143 , pp. 41-53
    • Fraser, J.R.1    Laurent, T.C.2
  • 10
    • 0030790353 scopus 로고    scopus 로고
    • High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival
    • Dietrich A., Tanczos E., Vanscheidt W., Schopf E., Simon J.C. High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur. J. Cancer 1997, 33(6):926-930.
    • (1997) Eur. J. Cancer , vol.33 , Issue.6 , pp. 926-930
    • Dietrich, A.1    Tanczos, E.2    Vanscheidt, W.3    Schopf, E.4    Simon, J.C.5
  • 11
    • 33751270222 scopus 로고    scopus 로고
    • Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective
    • Gotte M., Yip G.W. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 2006, 66(21):10233-10237.
    • (2006) Cancer Res. , vol.66 , Issue.21 , pp. 10233-10237
    • Gotte, M.1    Yip, G.W.2
  • 12
    • 20144385541 scopus 로고    scopus 로고
    • Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2
    • Misra S., Ghatak S., Toole B.P. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J. Biol. Chem. 2005, 280(21):20310-20315.
    • (2005) J. Biol. Chem. , vol.280 , Issue.21 , pp. 20310-20315
    • Misra, S.1    Ghatak, S.2    Toole, B.P.3
  • 13
    • 0028216487 scopus 로고
    • Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development
    • Bartolazzi A., Peach R., Aruffo A., Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 1994, 180(1):53-66.
    • (1994) J. Exp. Med. , vol.180 , Issue.1 , pp. 53-66
    • Bartolazzi, A.1    Peach, R.2    Aruffo, A.3    Stamenkovic, I.4
  • 14
    • 0027978978 scopus 로고
    • Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells
    • Asplund T., Heldin P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 1994, 54(16):4516-4523.
    • (1994) Cancer Res. , vol.54 , Issue.16 , pp. 4516-4523
    • Asplund, T.1    Heldin, P.2
  • 15
    • 0034986101 scopus 로고    scopus 로고
    • Characteristics of tissue distribution of various polysaccharides as drug carriers: influences of molecular weight and anionic charge on tumor targeting
    • Sugahara S., Okuno S., Yano T., Hamana H., Inoue K. Characteristics of tissue distribution of various polysaccharides as drug carriers: influences of molecular weight and anionic charge on tumor targeting. Biol. Pharm. Bull. 2001, 24(5):535-543.
    • (2001) Biol. Pharm. Bull. , vol.24 , Issue.5 , pp. 535-543
    • Sugahara, S.1    Okuno, S.2    Yano, T.3    Hamana, H.4    Inoue, K.5
  • 16
    • 0026561154 scopus 로고
    • Water-soluble polysaccharide-anthracycline conjugates: biological activity
    • Cera C., Palumbo M., Stefanelli S., Rassu M., Palu G. Water-soluble polysaccharide-anthracycline conjugates: biological activity. Anticancer Drug Des. 1992, 7(2):143-151.
    • (1992) Anticancer Drug Des. , vol.7 , Issue.2 , pp. 143-151
    • Cera, C.1    Palumbo, M.2    Stefanelli, S.3    Rassu, M.4    Palu, G.5
  • 18
    • 0033200301 scopus 로고    scopus 로고
    • Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate
    • Luo Y., Prestwich G.D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug. Chem. 1999, 10(5):755-763.
    • (1999) Bioconjug. Chem. , vol.10 , Issue.5 , pp. 755-763
    • Luo, Y.1    Prestwich, G.D.2
  • 19
    • 0034897891 scopus 로고    scopus 로고
    • Hydrogels for combination delivery of antineoplastic agents
    • Bouhadir K.H., Alsberg E., Mooney D.J. Hydrogels for combination delivery of antineoplastic agents. Biomaterials 2001, 22(19):2625-2633.
    • (2001) Biomaterials , vol.22 , Issue.19 , pp. 2625-2633
    • Bouhadir, K.H.1    Alsberg, E.2    Mooney, D.J.3
  • 20
    • 40849085410 scopus 로고    scopus 로고
    • Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking
    • Xu X., Sutak R., Richardson D.R. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking. Mol. Pharmacol. 2008, 73(3):833-844.
    • (2008) Mol. Pharmacol. , vol.73 , Issue.3 , pp. 833-844
    • Xu, X.1    Sutak, R.2    Richardson, D.R.3
  • 21
    • 43549084331 scopus 로고    scopus 로고
    • Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate
    • Cai S., Xie Y., Bagby T., Cohen M.S., Forrest M.L. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J. Surg. Res. 2008, 147(2):247-252.
    • (2008) J. Surg. Res. , vol.147 , Issue.2 , pp. 247-252
    • Cai, S.1    Xie, Y.2    Bagby, T.3    Cohen, M.S.4    Forrest, M.L.5
  • 22
    • 67549104172 scopus 로고    scopus 로고
    • Intratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations
    • Al-Ghananeem A.H.M.A.M., Muammer Y.M., Balko J.M., Black E.P., Mourad W., Romond E. Intratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations. AAPS PharmSciTech 2009, 10(2):410-417.
    • (2009) AAPS PharmSciTech , vol.10 , Issue.2 , pp. 410-417
    • Al-Ghananeem, A.H.M.A.M.1    Muammer, Y.M.2    Balko, J.M.3    Black, E.P.4    Mourad, W.5    Romond, E.6
  • 23
    • 0347285397 scopus 로고    scopus 로고
    • Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models
    • Peer R.M.D. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int. J. Cancer 2004, 108(5):780-789.
    • (2004) Int. J. Cancer , vol.108 , Issue.5 , pp. 780-789
    • Peer, R.M.D.1
  • 24
    • 36749030021 scopus 로고    scopus 로고
    • Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin
    • Yadav A.K., Mishra P., Mishra A.K., Jain S., Agrawal G.P. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 2007, 3(4):246-257.
    • (2007) Nanomedicine , vol.3 , Issue.4 , pp. 246-257
    • Yadav, A.K.1    Mishra, P.2    Mishra, A.K.3    Jain, S.4    Agrawal, G.P.5
  • 25
    • 47649103158 scopus 로고    scopus 로고
    • Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin
    • Yadav A.K., Mishra P., Jain S., Mishra A.K., Agrawal G.P. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. J. Drug Target. 2008, 16(6):464-478.
    • (2008) J. Drug Target. , vol.16 , Issue.6 , pp. 464-478
    • Yadav, A.K.1    Mishra, P.2    Jain, S.3    Mishra, A.K.4    Agrawal, G.P.5
  • 26
    • 66849083442 scopus 로고    scopus 로고
    • Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin
    • Lee H., Ahn C.H., Park T.G. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol. Biosci. 2009, 9(4):336-342.
    • (2009) Macromol. Biosci. , vol.9 , Issue.4 , pp. 336-342
    • Lee, H.1    Ahn, C.H.2    Park, T.G.3
  • 27
    • 41349087510 scopus 로고    scopus 로고
    • Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin
    • Soloman R., Gabizon A.A. Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin. Clin. Lymphoma Myeloma 2008, 8(1):21-32.
    • (2008) Clin. Lymphoma Myeloma , vol.8 , Issue.1 , pp. 21-32
    • Soloman, R.1    Gabizon, A.A.2
  • 28
    • 34547852276 scopus 로고    scopus 로고
    • Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome)
    • Lorusso D., Stefano A.D., Carone V., Fagotti A., Pisconti S., Scambia G. Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). Ann. Oncol. 2007, 18(7):1159-1164.
    • (2007) Ann. Oncol. , vol.18 , Issue.7 , pp. 1159-1164
    • Lorusso, D.1    Stefano, A.D.2    Carone, V.3    Fagotti, A.4    Pisconti, S.5    Scambia, G.6
  • 29
    • 11144357506 scopus 로고    scopus 로고
    • Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
    • O'Brien M.E., Wigler N., Inbar M., Rosso R., Grischke E., Santoro A., Catane R., Kieback D.G., Tomczak P., Ackland S.P., Orlandi F., Mellars L., Alland L., Tendler C. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann. Oncol. 2004, 15(3):440-449.
    • (2004) Ann. Oncol. , vol.15 , Issue.3 , pp. 440-449
    • O'Brien, M.E.1    Wigler, N.2    Inbar, M.3    Rosso, R.4    Grischke, E.5    Santoro, A.6    Catane, R.7    Kieback, D.G.8    Tomczak, P.9    Ackland, S.P.10    Orlandi, F.11    Mellars, L.12    Alland, L.13    Tendler, C.14
  • 31
    • 0025051505 scopus 로고
    • Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
    • Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 1990, 4(13):3076-3086.
    • (1990) FASEB J. , vol.4 , Issue.13 , pp. 3076-3086
    • Olson, R.D.1    Mushlin, P.S.2
  • 32
    • 20044376571 scopus 로고    scopus 로고
    • In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment
    • Quesada A.J., Nelius T., Yap R., Zaichuk T.A., Alfranca A., Filleur S., Volpert O.V., Redondo J.M. In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment. Cell Death Differ. 2005, 12(6):649-658.
    • (2005) Cell Death Differ. , vol.12 , Issue.6 , pp. 649-658
    • Quesada, A.J.1    Nelius, T.2    Yap, R.3    Zaichuk, T.A.4    Alfranca, A.5    Filleur, S.6    Volpert, O.V.7    Redondo, J.M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.